Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure

Circulation. 2006 Oct 24;114(17):1883-91. doi: 10.1161/CIRCULATIONAHA.106.632208.
No abstract available

Publication types

  • Congress
  • Research Support, N.I.H., Extramural

MeSH terms

  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Basic Helix-Loop-Helix Transcription Factors / physiology
  • Eisenmenger Complex / etiology
  • Eisenmenger Complex / physiopathology
  • Epoprostenol / therapeutic use
  • Forecasting
  • Genetic Predisposition to Disease
  • Humans
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / physiopathology
  • Myocardial Infarction / complications
  • Peptidyl-Dipeptidase A / genetics
  • Polymorphism, Genetic
  • Pressure
  • Pulmonary Heart Disease / etiology
  • Pulmonary Heart Disease / physiopathology
  • Transcription, Genetic
  • Tricuspid Valve Insufficiency / complications
  • Tricuspid Valve Insufficiency / physiopathology
  • Vasodilator Agents / therapeutic use
  • Ventricular Dysfunction, Left / complications
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Dysfunction, Right / drug therapy
  • Ventricular Dysfunction, Right / etiology
  • Ventricular Dysfunction, Right / genetics
  • Ventricular Dysfunction, Right / physiopathology*
  • Ventricular Function*

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • HAND2 protein, human
  • Vasodilator Agents
  • helix-loop-helix protein, eHAND
  • Epoprostenol
  • Peptidyl-Dipeptidase A